Polygenic Risk Score and Statin Relative Risk Reduction for Primary Prevention of Myocardial Infarction in a Real‐World Population-Reference-Cited by-同舟云学术

Polygenic Risk Score and Statin Relative Risk Reduction for Primary Prevention of Myocardial Infarction in a Real‐World Population

Published:2022-08-24 Issue:5 Volume:112 Page:1070-1078
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Oni‐Orisan Akinyemi¹²³^ORCID,Haldar Tanushree¹,Cayabyab Mari A.S.¹^ORCID,Ranatunga Dilrini K.⁴,Hoffmann Thomas J.²⁵^ORCID,Iribarren Carlos⁴,Krauss Ronald M.⁶⁷^ORCID,Risch Neil²⁴⁵

Affiliation:

1. Department of Clinical Pharmacy University of California San Francisco San Francisco California USA

2. Institute for Human Genetics, University of California San Francisco San Francisco California USA

3. Department of Bioengineering and Therapeutic Sciences University of California San Francisco San Francisco California USA

4. Kaiser Permanente Division of Research Oakland California USA

5. Department of Epidemiology and Biostatistics University of California San Francisco San Francisco California USA

6. Department of Pediatrics University of California San Francisco Oakland California USA

7. Department of Medicine University of California San Francisco Oakland California USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2715

Reference36 articles.

1. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

2. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

3. Large-scale association analysis identifies new risk loci for coronary artery disease

4. A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease

5. Coding Variation inANGPTL4,LPL,andSVEP1and the Risk of Coronary Disease

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics polygenic risk score: Ready or not for prime time?;Clinical and Translational Science;2024-07-30

2. Recent advances in polygenic scores: translation, equitability, methods and FAIR tools;Genome Medicine;2024-02-19

3. An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers;Clinical Pharmacology & Therapeutics;2023-06-12

4. Cardiovascular Disease Risk Assessment Using Traditional Risk Factors and Polygenic Risk Scores in the Million Veteran Program;JAMA Cardiology;2023-06-01

5. The Prospect of Genomic, Transcriptomic, Epigenetic and Metabolomic Biomarkers for The Personalized Prevention of Type 2 Diabetes and Cardiovascular Diseases;Current Vascular Pharmacology;2023-05